| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 2 |
| 1 | EZETIMIBE | 2 |
| 2 | ROSUVASTATIN | 2 |
| 3 | ACETAMINOPHEN | 1 |
| 4 | ACETAMINOPHEN 500MG | 1 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 6 | BISOPROLOL FUMARATE | 1 |
| 7 | BRENTUXIMAB VEDOTIN | 1 |
| 8 | CLEVIDIPINE | 1 |
| 9 | CLEVIPIDINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLEVIDIPINE | 1 | 0.0027 |
| 1 | OLEZARSEN SODIUM | 1 | 0.0011 |
| 2 | INCLISIRAN | 1 | 0.0001 |
| 3 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| 4 | LINAGLIPTIN | 1 | 0.0001 |
| 5 | ORLISTAT | 1 | 0.0000 |
| 6 | PERTUZUMAB | 1 | 0.0000 |
| 7 | EMPAGLIFLOZIN | 2 | 0.0000 |
| 8 | DOXAZOSIN MESYLATE | 1 | 0.0000 |
| 9 | EZETIMIBE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 1 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 | 0.0000 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 9 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |